Ask AI
ProCE Banner Events

Share

A Seat at the HS Expert’s Table: A Master Class in Diagnosis and Treatment Advances for Hidradenitis Suppurativa

This expert-led master class brings together leading HCPs to explore the latest advances in the diagnosis and management of hidradenitis suppurativa (HS). 

This INC Program does not qualify for continuing medical education (CME) credit and is independent of the official AAD Meeting as planned by the Scientific Assembly Committee.

Who Should Attend

This activity is intended for dermatologists, dermatology residents and fellows, nurse practitioners, physician associates, and other HCPs who care for patients with hidradenitis suppurativa.

Time and location

Thursday, March 26, 2026

6:30 PM - 8:30 PM Mountain Time (MT)

In-person

7:00 PM - 8:30 PM Mountain Time (MT)

Virtual

Embassy Suites Denver Convention Center
1420 Stout Street
Denver, Colorado 80202

Room: Silverton Ballroom

Agenda

Welcome, Introduction, and Baseline Assessment

Spotting HS: Clinical Presentation, Diagnosis, and Pathogenesis

  • HS phenotypes, typical lesions, and locations
  • Implications of delayed diagnosis
  • Consensus-driven clinical diagnostic criteria
  • Risk factors for developing HS
  • Key cytokines driving HS inflammation/progression
  • Master class interactive case discussions

Advances in HS Management

  • Approved targeted therapies
  • Emerging therapies
  • Selecting patient candidates
  • Master class interactive case discussions

Patient-Centered Care and Long-term Management in HS

  • QoL considerations
  • Addressing comorbidities
  • Patient education
  • Addressing barriers to health equity
  • Master class interactive case discussions

Key Takeaways and Posteducation Assessment

Location

Venue Name

Embassy Suites Denver Convention Center

Address

Embassy Suites Denver Convention Center
1420 Stout Street
Denver, Colorado 80202

Room Name

Room: Silverton Ballroom

CME/CE Info

Goal
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize the identification and management of patients with hidradenitis suppurativa.

Target Audience
This activity is intended for dermatologists, dermatology residents and fellows, nurse practitioners, physician associates, and other HCPs who care for patients with hidradenitis suppurativa.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply consensus-driven diagnostic strategies to enhance the accuracy and timeliness of HS diagnosis

  • Examine key elements of HS pathophysiology, including how they contribute to disease progression and the therapeutic rationale for targeting them with novel and emerging agents

  • Assess available and emerging targeted therapies for HS according to clinical profile, safety, and efficacy

  • Formulate comprehensive care plans that consider QoL and comorbidities for patients with HS, including those with skin of color

Accreditation

This activity is not certified for CME/CE credit.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education, in partnership with the HS Foundation

Clinical Care Options, LLC dba Decera Clinical Education

Supporter

Supported by educational grants from Incyte Corporation, Novartis Pharmaceuticals Corporation, and UCB Inc.

Incyte Corporation

Novartis Pharmaceuticals Corporation

UCB Inc.

Partner

HS Foundation

HS Foundation

Contact Information

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.